1. Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate
   Ismail Siti Mariam et al, 2022, Frontiers in Oncology CrossRef
2. SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS
   I. V. Dmytrenko et al, 2019, International Journal of Medicine and Medical Research CrossRef
3. Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights
   Miriam Iezza et al, 2023, Cells CrossRef